In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging.
about
Assessment of multifunctional contrast agent probes in neuroimaging: Implications of nanopharmaceutical therapeutic interventionsNanoparticulate carriers for the treatment of coronary restenosisHigh-Throughput Approaches to the Development of Molecular Imaging Agents.Imaging VCAM-1 as an indicator of treatment efficacy in metastatic ovarian cancerTechniques for molecular imaging probe designMolecular imaging of inflammation in atherosclerosis.Targeted delivery of therapeutics to endothelium.Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.Combinatorial peptide libraries: mining for cell-binding peptides.Display technologies: application for the discovery of drug and gene delivery agents.Targeted delivery of multifunctional magnetic nanoparticles.Mouse thymus targeted peptide isolated by in vivo phage display can inhibit bioactivity of thymus output in vivo.Phage display selection of peptides that home to atherosclerotic plaques: IL-4 receptor as a candidate target in atherosclerosis.Selective targeting of nanocarriers to neutrophils and monocytes.Potential of phage-displayed peptide library technology to identify functional targeting peptidesPhage display in molecular imaging and diagnosis of cancer.Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in miceEmerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.Phage display and molecular imaging: expanding fields of vision in living subjects.Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures.By-passing large screening experiments using sequencing as a tool to identify scFv fragments targeting atherosclerotic lesions in a novel in vivo phage display selection.Imaging ligand-dependent activation of CXCR7.Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient miceInhibition of atherosclerosis-promoting microRNAs via targeted polyelectrolyte complex micelles.Peptide-directed highly selective targeting of pulmonary arterial hypertension.Non-invasive detection of vulnerable coronary plaque.Phage-display-guided nanocarrier targeting to atheroprone vasculature.Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE(-/-) Mice.Molecular imaging of atherosclerosis for improving diagnostic and therapeutic developmentCharacterization of In Vivo Selected Bacteriophage for the Development of Novel Tumor-Targeting Agents with Specific Pharmacokinetics and Imaging Applications.Microfluidic system for facilitated quantification of nanoparticle accumulation to cells under laminar flowThe cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium.Molecular imaging of bacterial infections in vivo: the discrimination of infection from inflammation.Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery.Targeting and therapeutic peptides in nanomedicine for atherosclerosis.Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications.Molecular imaging in cardiovascular magnetic resonance imaging: current perspective and future potential.Nanovehicular intracellular delivery systems.Multifunctional magnetic nanoparticles for targeted imaging and therapyMagnetic nanoparticles in MR imaging and drug delivery.
P2860
Q27002379-4BA1B36C-0747-4562-9E1C-3E394E63675EQ28220309-5262D358-FE4A-4178-B99B-4E22E73350B7Q30275493-E8F4124B-9884-49F3-92DF-893675A33704Q30413757-C04E383E-302A-40DD-9F6E-FB1ED3D0BC8EQ30423734-EE8786E8-3AD4-4F80-BBF1-2422599934F6Q30446268-7A09B57A-F67D-485D-8B19-42FA2FEF433DQ30475849-337346E6-5CE9-49C0-8BC1-3643532F1B50Q30484224-2A9FBF4C-89FF-42A7-B340-773B7B2CEB20Q31144876-0DD770BD-D734-457A-B332-E620E0D0408BQ33264491-3AB72D5E-4812-4F8F-8742-BA2FAB4AFFB3Q33294984-39A98276-6E49-4DCA-98C2-2DBC987FE27DQ33382036-0F11B2DF-CC08-4762-AA70-AE7355985D77Q33384724-2240A6ED-8926-451C-87A0-6D7D4232CD19Q33433964-9A08F0D1-EE39-4DF7-847D-2FF6FC41F00CQ33530848-0DF73F30-9F0E-444F-8359-2557A38B4D10Q33532734-DAA8CED1-8279-44E9-8EA9-F5ED14E0FFD0Q33680616-BA79A73F-36FF-4B83-988A-1CA369DFA74BQ33839384-33A7B3D4-04E1-4324-9707-3017725218F1Q33849788-E213B3E9-3073-4435-B3F6-83EED9C68540Q34017152-0FD4550C-7723-43C2-B295-9F25E000C35CQ34353740-BAEE1513-FE40-456F-8D4D-A0FA4CFF7BB8Q34659164-0077BC4D-8DB9-4BB1-A2F6-7F81B805B801Q34880268-0325A41E-92E2-44E6-98C9-24BA43BAE6D8Q35067820-E6AA457D-CD5B-44D7-B09D-81257FD49EFBQ35070520-A91E3C17-2677-42CE-8FFC-834843FBE2DEQ35172896-79DBF0DB-8206-4BAB-8D88-6D5403CACD11Q35576617-3169B84B-E551-42B3-81E2-0C0D0C6F1596Q36089057-26E32A3E-EE39-4F54-AE9A-8C06AE393050Q36141999-904EB815-0C89-4C58-9E7C-5D978A9B1B6AQ36309972-6880D3A1-1141-45F1-AB02-059A1A903854Q36421741-5CD1D0EF-16C9-4EB9-BCC3-9DA8D59D6A06Q36555535-68C7E60B-1778-43AC-A78E-4A8E308A1BB9Q36683890-485D7411-AF30-4A44-9B07-2989D3B9BEEBQ36870151-AA4131ED-A41E-4019-93AD-080A22B4D445Q36913594-5B832626-C747-46EC-914E-65C69BB0B726Q37002415-F9EC50DE-B7F7-4839-9859-C3D6A703B7DAQ37002432-609349BA-6D48-4782-A719-E6A5ACF31B27Q37058812-CD6C269C-3670-4DEE-AD03-3D201D73A0CAQ37174947-7B45C797-BE99-46C5-BEB4-52B2E95F58E7Q37192908-309F4029-BD58-4F20-B5EE-11704B0B98A0
P2860
In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
In vivo phage display selectio ...... targeted peptides for imaging.
@ast
In vivo phage display selectio ...... targeted peptides for imaging.
@en
type
label
In vivo phage display selectio ...... targeted peptides for imaging.
@ast
In vivo phage display selectio ...... targeted peptides for imaging.
@en
prefLabel
In vivo phage display selectio ...... targeted peptides for imaging.
@ast
In vivo phage display selectio ...... targeted peptides for imaging.
@en
P2093
P2860
P1476
In vivo phage display selectio ...... targeted peptides for imaging.
@en
P2093
Fred Reynolds
Kimberly A Kelly
Matthias Nahrendorf
P2860
P2888
P304
P356
10.1007/S11307-006-0043-6
P577
2006-07-01T00:00:00Z